The Role of ERBB2/HER2 Tyrosine Kinase Receptor in the Regulation of Cell Death

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Human Epidermal Growth Factor Receptor 2 (HER2), also known as ERBB2, is a key member of the epidermal growth factor receptor (EGFR) family.
• Aberrant HER2 signaling, including overexpression and mutations, is implicated in various cancers, driving tumor proliferation, migration, and therapeutic resistance.
• Approved anti-HER2 therapies, including monoclonal antibodies and tyrosine kinase inhibitors, target HER2-driven cancers.

Purpose of the Study:

• To review the involvement of HER2 in diverse cellular signaling pathways.
• To elucidate the role of HER2 in the regulation of programmed cell death (apoptosis).
• To consolidate current understanding of HER2's multifaceted functions in cancer biology and therapy.

Main Methods:

• Literature review of studies investigating HER2 signaling pathways.
• Analysis of research focusing on HER2's role in apoptosis regulation.
• Synthesis of findings on HER2's impact on cancer cell proliferation, migration, and treatment resistance.

Main Results:

• HER2 activation stimulates molecular cascades promoting cancer cell proliferation and migration.
• HER2 signaling contributes to cancer cell survival under stress and resistance to anticancer therapies.
• HER2 directly influences the regulation of programmed cell death.

Conclusions:

• HER2 is a critical regulator of cancer cell behavior, including proliferation, survival, and apoptosis.
• Understanding HER2's complex signaling network is essential for developing effective anti-cancer strategies.
• Targeting HER2 remains a vital therapeutic approach for HER2-driven solid tumors.